Science Explorer Back to mapMap
Discussion
Researcher · University Hospital of Zurich · Switzerland

Enos Bernasconi

Enos Bernasconi publishes mostly in Infectious Diseases, Virology and Epidemiology, on topics such as HIV/AIDS drug development and treatment, HIV Research and Treatment and HIV/AIDS Research and Interventions.

ORCID 0000-0002-9724-8373 OpenAlex
World rank
#246,708
of 7,710,434 ranked researchers
Rank in Switzerland
#4,821
of 80,918
Works
619
Citations
27k
Citations per work
43.8
h-index
82
i10-index 376Top 0.4% in Infectious Diseases
Enos Bernasconi

What does Enos Bernasconi research?

Enos Bernasconi's work is mostly in Medicine (60%), Immunology and Microbiology (13%).

Health Sciences: 370 works · 59.7% of their workMedicine: 370 works · 59.7% of their workInfectious Diseases: 189 works · 30.5% of their workEpidemiology: 71 works · 11.4% of their workEmergency Medicine: 65 works · 10.5% of their workHepatology: 27 works · 4.3% of their workSurgery: 19 works · 3.0% of their workEverything else: 171 works · 27.6% of their workLife Sciences: 79 works · 12.7% of their workImmunology and Microbiology: 79 works · 12.7% of their workVirology: 79 works · 12.7% of their workTHEIR WORKEnos Bernasconi619works
Life Sciences13%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine37059.7%
  2. Everything else17127.6%
    1. Immunology and Microbiology7912.7%
  1. 1Infectious Diseases30% of their works
  2. 2Virology13% of their works
  3. 3Epidemiology11% of their works
  4. 4Emergency Medicine10% of their works
  5. 5Hepatology4% of their works
  6. 6Surgery3% of their works

Research topics

Which keywords describe Enos Bernasconi's research?

The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, Immune Response, HIV, Drug Resistance, Integrase Inhibitors, AIDS and Vaccine.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 24 words, with their numbers
  1. Antiretroviral Therapy7855 topics
  2. HIV Infection3712 topics
  3. Immune Response2833 topics
  4. HIV2553 topics
  5. Drug Resistance2061 topic
  6. Integrase Inhibitors2061 topic
  7. AIDS2001 topic
  8. Vaccine2001 topic
  9. HIV Transmission1901 topic
  10. Preexposure Prophylaxis1901 topic
  11. Cardiovascular Disease1651 topic
  12. Inflammation1651 topic
  13. Epidemiology1123 topics
  14. Antiviral Therapy832 topics
  15. Liver Disease832 topics
  16. Treatment812 topics
  17. Hepatitis C Virus571 topic
  18. Ribavirin571 topic
  19. drug use311 topic
  20. harm reduction311 topic
  21. Chronic Hepatitis B261 topic
  22. Hepatitis B Virus261 topic
  23. Pneumocystis241 topic
  24. Pneumonia241 topic

Where does Enos Bernasconi work?

Enos Bernasconi's main affiliation in the publication record is University Hospital of Zurich, Switzerland.

How many publications and citations does Enos Bernasconi have?

OpenAlex counts 619 works and 27,110 citations for Enos Bernasconi, an h-index of 82, ranking #246,708 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Enos Bernasconi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.